USFDA approves AstraZeneca diabetes drug for treating heart failure risk - The Time 2019

Catch the Biggest News-breaks

Monday, October 21, 2019

USFDA approves AstraZeneca diabetes drug for treating heart failure risk

USFDA approves AstraZeneca diabetes drug for treating heart failure risk The approval by the U.S. Food and Drug Administration is based on results from the DECLARE-TIMI 58 clinical trial, the London-listed company said, and follows a similar approval by the European authorities in August.

from Moneycontrol World News http://bit.ly/2p35AZ5

No comments:

Post a Comment

e